Back to Search Start Over

Blinatumomab is Safe and Effective in Relapsed and MRD Positive B-ALL CD19+ Patients: the Bologna Compassionate Program Experience.

Details

Language :
English
ISSN :
21522650
Volume :
16
Database :
Complementary Index
Journal :
Clinical Lymphoma, Myeloma & Leukemia
Publication Type :
Academic Journal
Accession number :
117709040
Full Text :
https://doi.org/10.1016/j.clml.2016.07.022